ArticleScientific reports2024

Comparative transcriptomic analysis validates iPSC derived in-vitro progressive fibrosis model as a screening tool for drug discovery and development in systemic sclerosis.

Shyam Nathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.